Lincoln Pharma expects export business to cross Rs225cr in FY20
The Company is also expanding portfolio in lifestyle and chronic segment especially in women healthcare and dermatology to complement its strong presence in the acute segment.
from India Infoline News Service https://ift.tt/2IsUMJO
No comments:
Post a Comment